This site is intended for healthcare professionals only
LoginRegister
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer, Valneva report positive pediatric, adolescent phase 2 booster results for Lyme disease...
Daiichi Sankyo submits sNDA for Omicron XBB.1.5-adapted COVID vaccine in JapanDaiichi Sankyo submits sNDA for Omicron XBB.1.5-adapted COVID vaccine in Japan
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaEuropean Commission expands Merck Ervebo indication to include children 1 year of age and older
State-Wide Immunization Drive in Haryana Targets High-Risk AreasMpox vaccine effective in decreasing severity of monkeypox infection: The Lancet Infectious Diseases...
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer-BioNTech updated COVID vaccine approved by UK regulator
Impact of COVID-19 vaccination on mortality after acute myocardial infarctionImpact of COVID-19 vaccination on mortality after acute myocardial infarction
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer, BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID vaccine in EU
CDSCO Panel Recommends Phase III Trial of Tetanus Vaccine by Indian Immunologicals in Pregnant WomenIndian Immunologicals expects to commercially launch dengue fever vaccine by early 2026
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic DermatitisPfizer gets European Commission marketing nod for RSV vaccine Abrysvo to protect infants, older...
Vaccinating children against COVID-19 effective in severe cases: BMJVaccinating children against COVID-19 effective in severe cases: BMJ
4-component protein-based vaccine highly effective against serogroup B invasive meningococcal disease: JAMA4-component protein-based vaccine highly effective against serogroup B invasive meningococcal...
First Vaccine for Pregnant Individuals to Prevent RSV in Infants approved by FDAFirst Vaccine for Pregnant Individuals to Prevent RSV in Infants approved by FDA
X